Summary
Sub-type selective ligands revealed a differential distribution of endothelin (ET) receptors within human adrenal glands. High densities of ETA receptors were localized, using [125I]-PD151242, to the smooth muscle layer of the arteries, smaller vessels within the capsular plexus and to the secretory cells of zona glomerulosa (K D=139.8±39.7,B max=69.7±9.1 fmol mg−1 protein, mean of 3 individuals±sem). ETB receptors were present in the medulla (K D=145.2±16.4,B max=75.5±12.3), zona glomerulosa (KD=100.6±35.1,B max=63.1±10.0), fasiculata (K D 145.1±162.,B max=67.9±6.9) and reticularis (KD=118.2±18.6,B max=71.9±6.5). ETB receptors were not detected within the smooth muscle of the vasculature. Messenger RNA encoding both sub-types was present in adrenals. ET-like immunoreactivity was localized to the cytoplasm of the endothelial cells from arteries supplying the gland and resistance vessels within the capsular plexus. Staining was also detected in these cells using anti-big ET-1 and less intensely with anti-big ET-2 antisera but not within cells within the cortex or medulla. Big ET-3-like immunoreactivity was localized to secretory cells of the medulla. Staining was not found using antiserum that could detect ET-3, suggesting further processing of big ET-3 may occur within the plasma, and that the cdrenals could be a source of ET-3. The presence of ET-1 was confirmed by high performance liquid chromatography and radioimmunoassay although ET-3 was not detected. The results suggest that ET-1 is the predominant mature isoform, which is localized mainly to adrenal vasculature, particularly the capsular plexus, and may contribute to blood flow regulation in the gland.
Similar content being viewed by others
References
Bacon, C. R., Morrison, J. J., O'Reilly, G., Cameron, I. T. &Davenport, A. P. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242.J. Endocrinol. 144, 127–34.
Boarddr, M. R. &Marriott, D. B. (1991) Endothelin-1 stimulation of noradrenaline and adrenaline release from adrenal chromaffin cells.Biochem. Pharmacol. 41, 521–6.
Cameron, I. T., Plumpton, C., Champeney, R., Van Papendorp, C., Ashby, M. J. &Davenport, A. P. (1993) Identification of endothelin-1, endothelin-2 and endothelin-3 in human endometrium.J. Reproduction and Fertility 97, 251–5.
Cozza, E. N., Gomez Sanchez, C. E., Foecking, M. F. &Chiou, S. (1989) Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion.J. Clin. Invest. 84, 1032–5.
Cyr, C., Huebner, K., Druck, T. &Kris, R. (1991) Cloning and chromosomal localization of a human endothelin ETA receptor.Biochem. Biophys. Res. Commun. 181, 184–90.
Davenport, A. P. &Maguire, J. J. (1994) Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans?Trends Pharm. Sci. 15, 9–11.
Davenport, A. P., Nunez, D. J., Hall, J. A., Kaumann, A. J. &Brown, M. J. (1989) Autoradiographical localization of binding sites for porcine (125I)endothelin-1 in humans, pigs, and rats: Functional relevance in humans.J. Cardiovasc. Pharmacol. 13 (5), S166–70.
Davenport, A. P., O'reilly, G., Molenaar, P., Maguire, J. J., Kuc, R. E., Sharkey, A., Bacon, C. R. &Ferro, A. (1993) Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization and sub-type selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.J. Cardiovasc. Pharmacol. 22, S22–5.
Davenport, A. P., Kuc, R. E., Fitzgerald, F., Maguire, J. J., Berryman, K. &Doherty, A. M. (1994a) [125I]-PD151242: a selective radioligand for human ETA receptors.Br. J. Pharmacol. 111, 4–6.
Davenport, A. P., Kuc, R. E., Hoskins, S. L., Karet, F. E. &Fitzgerald, F. (1994b) [125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localises to renal vasculature.Br. J. Pharmacol. 113, 1303–10.
Davenport, A. P., O'reilly, G. &Kuc, R. E. (1995) Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA subtype.Br. J. Pharmacol. 114, 1110–16.
Gasic, S., Wagner, O. F., Vierhapper, H., Nowotny, P. &Waldhausl, W. (1992) Regional hemodynamic effects and clearance of endothelin-1 in humans: Renal and peripheral tissues may contribute to the overall disposal of the peptide.J. Cardiovasc. Pharmacol. 19, 176–80.
Hinson, J. P., Vinson, G. P., Kapas, S. &Teja, R. (1991) The role of endothelin in the control of adrenocortical function: stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin-3 on steroidogenesis in rat and human adrenocortical cells.J. Endocrinol. 128, 275–80.
Hirata, Y., Imai, T., Eguchi, S. &Marumo, F. (1993) Concomitant expression of endothelin receptor subtype and isopeptide by pheochromocytoma and bovine adrenal medulla.Hyperten. Res. 16, 215–19.
Howard, P. G., Plumption, C. &Davenport, A. P. 1992) Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue.J. Hyperten. 10, 1379–86.
Imai, T., Hirata, Y., Eguchi, S., Kanno, K., Ohta, K., Emori, T., Sakamoto, A., Yanagisawa, M., Masaki, T. &Marumo, F. (1992) Concomitant expression of receptor subtype and isopeptide of endothelin by human adrenal gland.Biochem. Biophys. Res. Commun. 182, 1115–21.
Karet, F. E. &Davenport, A. P. (1993) Human kidney: Endothelin isoforms detected by HPLC with radioimmunoassay and receptor subtypes detected using ligands BQ123 and BQ3020.J. Cardiovasc. Pharmacol. 22, S29–33.
Karet, F. E., Kuc, R. E. &Davenport, A. P. (1993) Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.Kidney International 44, 36–42.
Karet, F. E., Charnockjones, D. S., Harrison-Woolrych, M. L. H., O'reilly, G., Davenport, A. P. &Smith, S. K. (1994) Quantification of mRNA in human tissue using fluorescent nested reverse-transcriptase polymerase chain reaction.Anal. Biochem. 220, 384–90.
Kohzuki, M., Johnston, C. I., Chai, S. Y., Casley, D. J., Rogerson, F. &Mendelsohn, F. A. O. (1989) Endothelin receptors in rat adrenal gland visualized by quantitative autoradiography.Clin. Exp. Pharmacol. Physiol. 16, 239–42.
Maguire, J. J. &Davenport, A. P. (1995) ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.Br. J. Pharmacol. 115, 191–7.
Maguire, J. J., Kuc, R. E., O'reilly, G. &Davenport, A. P. (1994) Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro.Br. J. Pharmacol. 113, 49–54.
Marciniak, S. J., Plumpton, C., Barker, P. J., Huskisson N. S. &Davenport, A. P. (1992) Localization of immunoreactive endothelin and proendothelin in the human lung.Pulmon. Pharmacol. 5, 175–82.
Molenaar, P., Kuc, R. E. &Davenport, A. P. (1992) Characterisation of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1, 3, 11, 15JET-1 in human heart.Br. J. Pharmacol. 107, 637–9.
Molenaar, P., O'reilly, G., Sharkey, A., Kuc, R. E., Harding, D. P., Plumpton, C., Gresham, G. A., &Davenport, A. P. (1993) Characterisation and localization of endothelin receptor sub-types in the human atrioventricular conducting system and myocardium.Circ. Res. 72, 526–38.
Nakao, K., Arai, H., Hosoda, K., Ogawa, Y., Nakagawa, O., Suga, S. I., Nakanishi, S. &Imura, H. (1991) Molecular cloning of two subtypes of human endothelin receptor.J. Vasc. Med. Biol. 3, 303–7.
Naruse, M., Fujimaki, Y., Naruse, K., Yoshimoto, T., Kawai, M., Tanabe, A., Tanaka, M., Imaki, T., Shibasaki, T., Ito, Y., Obara, T., Hagiwara, H., Hirose, S., Yano, M., Demura, R., &Demura, H. (1995) Pathophysiological role of endothelin in adrenal gland: A local modulator of aldosterone secretion. InEndocrinology: New Advances (edited byBaldi, E., Maggi, M., Cameron, I. T. &Dunn, M. J.), pp. 241–53. Rome: Ares Serono Symposia.
O'Reilly, G., Charnock-Jones, D. S., Davenport, A. P., Cameron, I. T. &Smith, S. K. (1992) Presence of mRNA for endothelin-1, endothelin-2, and endothelin-3 in human endometrium, and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.J. Clin. Endocrin. Metabolism. 75, 1545–9.
Peter, M. G. &Davenport, A. P. (1995) Selectivity of (125I)-PD151242 for human, rat and porcine endothelin ETA receptors in the heart.Br. J. Pharmacol. 114, 297–302.
Pierre, L. N. &Davenport, A. P. (1995) Autoradiographic study of endothelin receptors in human cerebral arteries.J. Cardiovasc. Pharmacol.,26, S326–8.
Plumpton, C., Champeney, R., Ashby, M. J., Kuc, R. E. &Davenport, A. P. (1993) Characterization of endothelin isoforms in human heart: Endothelin-2 demonstrated.J. Cardiovasc. Pharmacol. 22, S26–8.
Plumpton, C., Haynes, W. G., Webb, D. J. &Davenport, A. P. (1995) Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm.Br. J. Pharmacol. 115, 1821–8.
Plumpton, C., Ashby, M. J., Kuc, R. E., O'reilly, G. &Davenport, A. P. (1996) Expression of endothelin peptides and mRNA in the human heart.Clin. Sci. 89, 37–46.
Rossi, G., Albertin, G., Belloni, A., Zanin, L., Biasolo, M. A., Prayergaletti, T., Bader, M., Nussdorfer, G. G., Palu, G. &Pessina, A. C. (1994) Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.J. Clin. Invest. 94, 1226–34.
Suzuki, N., Matsumoto, H., Miyauchi, T., Goto, K., Masaki, T., Tsuda, M. &Fujino, M. (1990). Endothelin-3 concentrations in human plasma: the increased concentrations in patients undergoing haemodialysis.Biochem. Biophys. Res. Commun. 169, 809–15.
Vierhapper, H., Wagner, O., Nowotny, P. &Waldhausl, W. (1990) Effect of endothelin-1 in man.Circulation 81, 1415–18.
Vierhapper, H., Nowotny, P. &Waldhausl, W. (1995) Effect of endothelin-1 in man: Impact on basal adrenocorticotropin-stimulated concentrations of aldosterone.J. Clin. Endocrinol. Metab. 80, 948–51.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davenport, A.P., Hoskins, S.L., Kuc, R.E. et al. Differential distribution of endothelin peptides and receptors in human adrenal gland. Histochem J 28, 779–789 (1996). https://doi.org/10.1007/BF02272151
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02272151